A pilot multi-institutional study to evaluate the accuracy of a supine MRI based guidance system, the Breast Cancer Locator™, in patients with palpable breast cancer.

Autor: Barth RJ Jr; Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA; CairnSurgical, Inc, USA. Electronic address: Richard.J.Barth.Jr@Hitchcock.org., Krishnaswamy V; CairnSurgical, Inc, USA., Rooney TB; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA., Fox MJ; Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Burman HEG; Department of Surgery, Cheshire Medical Center, Keene, NH, USA., Rosenkranz KM; Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Gass J; Department of Surgery, Women and Infants Hospital, Providence, RI, USA., Bronfine BI; Department of Surgery, St. Joseph's Hospital, Nashua, NH, USA., Angeles CV; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Paulsen KD; Thayer School of Engineering, Hanover, NH, USA.
Jazyk: angličtina
Zdroj: Surgical oncology [Surg Oncol] 2022 Sep; Vol. 44, pp. 101843. Date of Electronic Publication: 2022 Aug 30.
DOI: 10.1016/j.suronc.2022.101843
Abstrakt: Background: Evaluate whether the Breast Cancer Locator™ (BCL), a novel guidance system based on supine MRI images, can be safely and effectively deployed by several surgeons at multiple sites.
Methods: Patients with palpable breast cancer underwent supine MRI at their local institution. A three dimensional (3D) digital image of the tumor in the breast was derived from supine MRI images and used to generate 1) an interactive 3D virtual image of the tumor in the breast (Visualizer) and 2) a plastic bra-like form that allowed the surgeon to place a central wire and bracketing wires in the breast (BCL). The primary objective was to determine the proportion of patients who had the central localization wire deployed within the cancer on specimen mammogram.
Results: Fourteen patients were enrolled at 4 different sites by 6 surgeons. BCLs were successfully manufactured for all patients. The central wire was deployed within the tumor on specimen mammogram in 12 of the 13 patients who had a central wire placed (92%). The cancer was excised with negative margins in 14/14 cases (100%). No adverse events occurred.
Conclusions: Supine MRI image acquisition was accomplished successfully across multiple sites. Multiple surgeons utilized the BCL system to localize cancers accurately and safely.
Competing Interests: Declaration of competing interest Drs. Barth, Krishnaswamy and Paulsen have ownership interest in CairnSurgical, Inc and are listed on patents relevant to the Breast Cancer Locator guidance system.
(Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: